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strong antibody signals indicating a previous or further active infec-
tion with M. fermentans. In contrast, MALP-404 antibodies were
not detected in any of the 14 matched controls examined (odds
ratios 46.07 and 2.05, respectively; po0.05). Four of the seven
MALP-404-positive patients (57%) but also nine of the 15
MALP-404-negative patients (60%) were HLA-B51-positive (odds
ratio 0.89, not signi¢cant). The presence of the MALP-404 antigen
did not correlate with any demographic data, the clinical signs or
the prognostic factors of the disease (not signi¢cant).
These data suggest that a high percentage of patients with ma-
lignant aphthosis present with antibodies against M. fermentans.
MALP-404 has been shown to be subject to site-speci¢c proteo-
lysis between residues 14 and 15 of the mature lipoprotein, result-
ing in the cell-bound MALP-2 and soluble released fragment
products (Davis and Wise, 2002). On the other hand, MALP-
404 is responsible for macrophage activation and macrophages
of healthy donors have been strongly activated by serum of pa-
tients with malignant aphthosis (Alpsoy et al, 2003). Therefore,
the possibility exists that a M. fermentans infection in patients with
malignant aphthosis predisposes these patients to a cross-reactive
autoimmune response and precipitates the disease (Sakane et al, 1999).
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Lack of Evidence for the Presence of SimianVirus 40 DNA in
Cutaneous Lymphomas
To the Editor:
Cutaneous lymphomas are the second most common extranodal
non-Hodgkin lymphoma (Connors et al, 2002) with an incidence
of 1 in 100,000 (Burg et al, 1994). The etiology remains unclear;
infectious agents (Goodlad et al, 2000; Erkek et al, 2001), as one
of the possible causes of the disease are discussed by several
authors. Simian virus 40 (SV40) is a DNA virus that can induce
various tumors in hamsters and rodents (Cicala et al, 1993), and
whose oncogenic potential has been demonstrated in multiple
human tumors, such as brain and bone tumors or mesotheliomas
(Jasani et al, 2001).
The capacity of SV40 to promote proliferation is due to its
large T antigen, which is primarily responsible for virus replica-
tion, and cell transformation. SV40 was mainly transmitted to
humans between 1955 and 1963 in contaminated batches of polio
vaccine (Kops, 2000). Although large epidemiologic studies with
patients vaccinated with the tainted vaccine did not show an in-
creased incidence of cancer (Carroll-Pankhurst et al, 2001), SV40
links to cancer grow stronger (Ferber, 2002).
Two recent studies report on the presence of SV40 in human
lymphomas (Shivapurkar et al, 2002; Vilchez et al, 2002). Large T
antigen DNA sequences were detected by polymerase chain reac-
tion (PCR) in 43% of all non-Hodgkin lymphomas and 9% of all
Hodgkin lymphomas; however, the association of the polyoma
virus with cutaneous lymphomas has not been investigated yet.
In this study, we screened the presence of the large T antigen
region of SV40 in 43 cutaneous lymphoproliferative disorders.
Fifteen cases of mycosis fungoides, 12 primary cutaneous B cell
lymphomas (eight extranodal marginal zone B cell lymphomas
of mucosa associated lymphoid tissue-type, three follicular lym-
phomas, one di¡use large B cell lymphoma), six cases of lympho-
matoid papulosis, and ten atypical lymphocytic in¢ltrates
(pseudolymphomas) with a predominant T cell immunopheno-
type were included in this study. Specimens were gathered from
diagnostic skin biopsies of Caucasian patients from the Depart-
ment of Dermatology, Ludwig-Maximilians-University (Mu-
nich, Germany). The mean age of our 43 patients was 61 y (SD
20 years, range 25^97 y). The patients included in the study lived
in Germany, none of our patients had undergone an organ trans-
plantation or showed features of immunosuppression. The his-
tologic diagnosis was made due to the morphology and immu-
nophenotype of the in¢ltrates.
In order to detect intralesional presence of SV40 large T anti-
gen 35 formalin-¢xed and para⁄n-embedded skin biopsies and
eight frozen tissue biopsies were cut in one 10 mm section each
and stained with hematoxylin.
The entire lymphocytic in¢ltrate (approximately 2000^4000
cells) was dissected with a PixCell II Laser Capture Microdissection
System (Arcturus Engineering Inc., MountainView, California).
The captured cells were immediately transferred to proteinase
K enriched digestion bu¡er. After an overnight incubation at
501C, proteinase was heat-inactivated. Presence of a su⁄cient
amount of DNA was assured by amplifying a fragment of the
b-globin gene (primers PCO3/KM38 (Saiki et al, 1985)) as an in-
ternal control.
For detection of SV40 large T antigen sequences, two di¡erent
sets of primers (PYV-forward/PYV-reverse and SV-forward/SV-
reverse) were used (Gamberi et al, 2000; David et al, 2001), ampli-
fying a 172 bp, respectively, a 574 bp product. PCRwere carried
out in a 30 mL reaction volume, containing 1PCR bu¡er (Ap-
plied Biosystems, Branchburg, New Jersey), 200 mM each deoxy-
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nucleotide triphosphate (Applied Biosystems), 0.5 mM forward
and reverse primer, and 1 unit of AmpliTaq Gold polymerase
(Applied Biosystems). After initial heating at 941C for 7 min, 45
cycles were carried out at: 30 s denaturation at 941C, 30 s anneal-
ing at 601C, 30 s extension at 721C, followed by a ¢nal extension
for 7 min at 721C.
The PCR products were run on a 1.5% agarose gel, stained
with ethidium bromide and visualized under ultraviolet light.
As a positive control for ampli¢cation of the SV40 sequences,
formalin-¢xed and para⁄n-embedded SV40-infected COS-7
cells (kindly provided by Beate Reinhardt, MD, Department of
Virology, University of Ulm) were used.Water control was used
as a negative control. Positive controls were added to the PCR
reactions after the tubes containing the negative control and the
test DNAwere closed.
To avoid contamination, PCR assays were set up in a clean
room with all post PCR procedures performed in separate rooms.
Gloves were changed frequently and sterile ¢lter tips were used.
For con¢rmation of our results, the 1.5% agarose gel was trans-
ferred to a nylon membrane and hybridized with the speci¢c
probe SV40, which carries a 50digoxigenin label, using the
DigEasyHyb Kit (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s instructions.
We screened 43 biopsies of lymphoproliferative disorders for
the presence of SV40 large T antigen sequences by PCR con-
¢rmed by Southern blot hybridization.
As shown inTable I, none of the 12 cutaneous B cell or 15 T
cell lymphomas nor cases of lymphomatoid papulosis (six cases
screened) were positive for SV40 large T antigen sequences, only
one atypical lymphocytic in¢ltrate (pseudolymphoma) showed a
positive result.
Our collective of cutaneous lymphomas shows a lower detection
rate compared with the results recently published by Shivapurkar
et al (2002) andVilchez et al (2002).These authors showed incidence
of SV40 sequences in about 40% of all non-Hodgkin lymphomas,
with lymphomas of B cell origin showing a higher frequency of
SV40 detection thanTcell lymphomas.
Apart from geographical reasons, the uneven distribution of
contaminated polio batches and di¡erences in the collectives
screened (15 of the 27 primary cutaneous lymphomas included
in this study were of T cell origin), the skin being the a¡ected
organ of the disease might also be a reason for the lack of detec-
tion of SV40 virus.The skin has a very unique immunologic host
defense making use of dendritic cells, keratinocytes that can pro-
duce various immunomodulatory cytokines, and distinctive po-
pulations of extravascular lymphocytes. This system is by some
authors referred to as skin-associated lymphoid tissue (Stingl and
Steiner, 1989; Giannotti and Santucci, 1993), which is unique for
its type of antigen response.
The only positive case of our collective was a biopsy of an aty-
pical lymphocytic in¢ltrate.
Several explanations concerning the pathogenesis of this dis-
ease have been postulated, ranging from an involvement of cellu-
lar immunity (Bachelez et al, 1998) to exogenous factors, such as
infections (Wagner et al, 1998) or drugs (Cogrel et al, 2001).
In conclusion, the high percentage of SV40-positive extracuta-
neous non-Hodgkin lymphomas compared with the complete
lack of detection of SV40 large T antigen in cutaneous non-
Hodgkin lymphomas of the same age suggests cutaneous lym-
phocytic in¢ltrates not being a reservoir of SV40.
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Table I. Presence of SV40 large T-antigen sequences
Diagnosis Number of cases Mean age (mean7SD) SV40 positive
Cutaneous B cell lymphoma 12 54725 0/12
MALT lymphomaa 8 0/8
Follicular lymphoma 3 0/3
Di¡use large B cell lymphoma 1 0/1
Mycosis fungoides 15 68715 0/15
Lymphomatoid papulosis 6 60717 0/6
Reactive lymphocytic in¢ltrate 10 61718 1/10
aExtranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma).
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